|
|
cell adhesion
|
GO:0007155 |
329 |
0.318
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.227
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.225
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.208
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.184
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.181
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.170
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.159
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.156
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.153
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.151
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.149
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
9 |
0.148
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.136
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.130
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.127
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.118
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.117
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.116
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.112
|
|
|
|
epithelial cell proliferation involved in prostatic bud elongation
|
GO:0060517 |
1 |
0.112
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.111
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.105
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.103
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.103
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.101
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.098
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.096
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.093
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.091
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.091
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.090
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.089
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.087
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.085
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.085
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.085
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.085
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.084
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.084
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.083
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.083
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.082
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.082
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.082
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.081
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.080
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.080
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.080
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.079
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.079
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.079
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.079
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.077
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.077
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.075
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.075
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.074
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.074
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.074
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.074
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.073
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.073
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.073
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.073
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.072
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.072
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.072
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.071
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.071
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.071
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.070
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.070
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.070
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.070
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.069
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.069
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.069
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.069
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.069
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.068
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.068
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.068
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.068
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.068
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.067
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.067
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.066
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.066
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.066
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.066
|
|
|
|
myeloid dendritic cell chemotaxis
|
GO:0002408 |
2 |
0.066
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.065
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.065
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.065
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.065
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.064
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.063
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.063
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.063
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.062
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.062
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.062
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.062
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.061
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.061
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.061
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.061
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.060
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.060
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.060
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.060
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.060
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.060
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.059
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.059
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.058
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
23 |
0.058
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.058
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.058
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.058
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.058
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.057
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.057
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.057
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.057
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.056
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.056
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.056
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.055
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.055
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.055
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.055
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.055
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.054
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.054
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.054
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.054
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.054
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.054
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.054
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.054
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.053
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.053
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.053
|
|
|
|
positive regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:0035793 |
1 |
0.053
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.053
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.052
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.052
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.052
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.051
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.051
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.051
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.051
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.051
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.050
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.050
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.050
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.050
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.048
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.048
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.048
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.048
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.047
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.047
|
|
|
|
negative regulation of photoreceptor cell differentiation
|
GO:0046533 |
4 |
0.047
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.047
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.047
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.047
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.047
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.047
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.046
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.046
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.045
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.045
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.045
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.045
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.045
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.045
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.045
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.044
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.044
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.044
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.044
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.044
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.044
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.043
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.043
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.043
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.043
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.042
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.042
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.041
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.041
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.041
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.041
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.041
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.041
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.041
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.041
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.041
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.040
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.040
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.040
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.040
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.040
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.040
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.039
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.039
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.038
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.038
|
|
|
|
cardiac endothelial cell differentiation
|
GO:0003348 |
4 |
0.038
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.038
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.038
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.037
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.037
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.037
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.036
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.035
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.035
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.035
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.035
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.035
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
bronchus cartilage development
|
GO:0060532 |
2 |
0.035
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.035
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.035
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.034
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.034
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.034
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.034
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.034
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.034
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.034
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.034
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.034
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.033
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.033
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.033
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.033
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.033
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.033
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.033
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.032
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.032
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.032
|
|
|
|
ephrin receptor signaling pathway
|
GO:0048013 |
20 |
0.032
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.032
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
|
regulation of podosome assembly
|
GO:0071801 |
3 |
0.032
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.032
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.032
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.031
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.031
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.031
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.031
|
|
|
|
detection of mechanical stimulus involved in equilibrioception
|
GO:0050973 |
2 |
0.031
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.031
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.031
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.031
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.031
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.031
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.031
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.031
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.030
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.030
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.030
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.030
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.030
|
|
|
|
renal vesicle morphogenesis
|
GO:0072077 |
15 |
0.030
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.030
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.030
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.030
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.030
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.030
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.029
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.029
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.029
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.029
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.029
|
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.029
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.029
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.029
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.029
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.029
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.029
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.029
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.029
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.029
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.028
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.028
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.028
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.028
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.028
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.028
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.028
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.028
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.028
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.028
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.028
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.028
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.028
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.027
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.027
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.027
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.027
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.027
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.027
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.027
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.027
|
|
|
|
pro t cell differentiation
|
GO:0002572 |
3 |
0.027
|
|
|
|
regulation of extracellular matrix assembly
|
GO:1901201 |
2 |
0.027
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.027
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.027
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.027
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.027
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.027
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.027
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.026
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.026
|
|
|
|
renal vesicle formation
|
GO:0072033 |
8 |
0.026
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.026
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.026
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.026
|
|
|
|
ascending aorta development
|
GO:0035905 |
3 |
0.026
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.026
|
|
|
|
negative regulation of synapse maturation
|
GO:2000297 |
2 |
0.026
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.026
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.026
|
|
|
|
cellular response to thyroid hormone stimulus
|
GO:0097067 |
1 |
0.026
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.026
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.026
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.026
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.025
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.025
|
|
|
|
striatal medium spiny neuron differentiation
|
GO:0021773 |
2 |
0.025
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.025
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.025
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.025
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.025
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.025
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.025
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.024
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.024
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.024
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.024
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.024
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.024
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.024
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.024
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.023
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.023
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.023
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.023
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.023
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.023
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.023
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.023
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.023
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.023
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.023
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.022
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.022
|
|
|
|
response to retinoic acid
|
GO:0032526 |
56 |
0.022
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.022
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.022
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.022
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.022
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.022
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.022
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.022
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.022
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.022
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.022
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.022
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.021
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.021
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.021
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.021
|
|
|
|
endocardium formation
|
GO:0060214 |
4 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.021
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.021
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.021
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.021
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.021
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.021
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.021
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.021
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.021
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.021
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.021
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.021
|
|
|
|
regulation of metanephric mesenchymal cell migration by platelet derived growth factor receptor beta signaling pathway
|
GO:1900238 |
1 |
0.021
|
|
|
|
erythropoietin mediated signaling pathway
|
GO:0038162 |
1 |
0.021
|
|
|
|
g0 to g1 transition
|
GO:0045023 |
3 |
0.021
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.021
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.021
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.021
|
|
|
|
response to heparin
|
GO:0071503 |
1 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.021
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.021
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.021
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.021
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.020
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.020
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.020
|
|
|
|
aorta development
|
GO:0035904 |
23 |
0.020
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.020
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.020
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.020
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.020
|
|
|
|
ventricular trabecula myocardium morphogenesis
|
GO:0003222 |
11 |
0.020
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.020
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.020
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.020
|
|
|
|
regulation of lens epithelial cell proliferation
|
GO:2001109 |
1 |
0.020
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.020
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.020
|
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.020
|
|
|
|
positive regulation of lens epithelial cell proliferation
|
GO:2001111 |
1 |
0.020
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.020
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.020
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.019
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.019
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
0.019
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.019
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.019
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.019
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.019
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.019
|
|
|
|
n methyl d aspartate receptor clustering
|
GO:0097114 |
3 |
0.019
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.019
|
|
|
|
venous blood vessel morphogenesis
|
GO:0048845 |
7 |
0.019
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.019
|
|
|
|
endothelial tube morphogenesis
|
GO:0061154 |
2 |
0.019
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.019
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.019
|
|
|
|
inner cell mass cellular morphogenesis
|
GO:0001828 |
1 |
0.019
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.019
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.019
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.019
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.019
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.019
|
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.019
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.019
|
|
|
|
response to erythropoietin
|
GO:0036017 |
1 |
0.019
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.019
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.018
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.018
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.018
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.018
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.018
|
|
